The Epstein-Barr virus latent membrane protein 1 regulates gene expression by engaging multiple signaling pathways

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Last Modified
  • March 21, 2019
Creator
  • Kung, Che-Pei
    • Affiliation: School of Medicine, Department of Microbiology and Immunology
Abstract
  • Epstein-Barr virus (EBV) is a ubiquitous human gammaherpesvirus that is associated with a variety of human malignancies of lymphoid and epithelial origins, such as post-transplant lymphoproliferative disorder (PTLD), Burkitt's lymphoma (BL), Hodgkin disease (HL), nasopharyngeal carcinoma, and others. Latent membrane protein 1 (LMP1), which is expressed in latency type II and III, is considered the EBV oncoprotein due to its ability to transform rodent fibroblasts and its critical roles in EBV-mediated B cell transformation. Two major signaling domains of LMP1, carboxyl-terminal activating region (CTAR) 1 and 2, are responsible for the majority of LMP1-mediated signaling pathways. However, CTAR1 and CTAR2 induce distinctive signal transductions and only CTAR1 is essential for LMP1-mediated cell transformation. CTAR1 recruits TNFR-associated factors (TRAFs) to induce signaling pathways including PI3K/Akt, MEK/ERK, and complex NF-[kappa]B signaling. CTAR1 is also responsible for LMP1-regulated expression of cellular genes, such as epidermal growth factor receptor (EGFR). In this study, multiple signaling pathways engaged by LMP1 through CTAR1 to mediate EGFR upregulation were evaluated. LMP1 has been shown to induce EGFR expression by activating transcriptional active complex p50-homodimer/Bcl-3. This study shows CTAR1 also induces the expression of Bcl-3 through activating transcriptional regulator of Bcl-3, STAT3, and the STAT3 activation is required for CTAR1's complete activity to induce EGFR expression. Using mouse embryonic fibroblasts (MEF) defective for different NF-[kappa]B effectors and TRAFs, we identified that CTAR1-mediated EGFR upregulation is dependent on NIK but not canonical or noncanonical NF-[kappa]B pathways. However NIK alone is not sufficient to induce EGFR expression, indicating that additional pathways are also needed. Consistent with previous studies, TRAF2 and TRAF3 but not TRAF6 are required for CTAR1-mediated EGFR induction. TRAF2 potentially contributes to EGFR induction by regulating p50 activation, and this activation is not mediated through the canonical or noncanonical NF-[kappa]B pathways. Both EGFR and STAT3 are activated by CTAR1 in a serum-independent manner, however, the CTAR1-activated EGFR can also activate STAT3 in response to EGF treatment and induce the expression of STAT3 target genes. CTAR1 was found to activate STAT3 through PKC[delta], as inhibition of PKC[delta] by a chemical inhibitor reduced CTAR1-induced serine phosphorylation of STAT3 and Bcl-3 expression. These findings indicate that CTAR1 manipulates STAT3 signaling through multiple mechanisms. PKC[delta] was also shown to mediate CTAR1-induced ERK activation, and inhibition of PKC[delta] block CTAR1-mediated transformation of rodent fibroblast cells. These results suggest that CTAR1 induce EGFR expression by engaging multiple downstream signaling pathways that contribute to LMP1-mediated gene regulation.
Date of publication
DOI
Resource type
Rights statement
  • In Copyright
Note
  • "... in the partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Microbiology and Immunology."
Advisor
  • Raab-Traub, Nancy
Degree granting institution
  • University of North Carolina at Chapel Hill
Language
Publisher
Place of publication
  • Chapel Hill, NC
Access right
  • Open access
Date uploaded
  • March 18, 2013

Relations

Parents:

This work has no parents.

Items

Thumbnail Title Date Uploaded Visibility Actions
file details The Epstein-Barr virus latent membrane protein 1 regulates gene expression by engaging multiple signaling pathways 2019-04-12 Public Download